Press release dated February 05, 2026, titled "Consolidated and Standalone Unaudited Financial Results for…
As filed · Sakar Healthcare Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Consolidated and Standalone Unaudited Financial Results for the quarter and nine months en
What happened
FactSakar Healthcare Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Consolidated and Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025". Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025 we. FOR, SAKAR HEALTHCARE LIMITED.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
RevisedSo, there we can look around doubling the sale year over year so that what we are trying to do this year as well as planning for the next year also which I have already told around 3x of the previous year figure what we achieved.
Roughly it was INR35 crores last year domestic CMO and this year we are going to double that number.
Change
FactImplication
CapitSignal interpretationCapex
RevisedSo, out of 21, seven will be having an approval with CEP maybe in next few quarters.
Another five already we have in the pipeline where we have processed for seven API, APIs with CEPs we are planning for within next few quarters, maybe two to three quarters.
Change
FactImplication
CapitSignal interpretationGuidance
Delayedthe potential we also are looking forward maybe down the line in around three to four years’ time.
it will be soon crossing the 30% margin EBITDA in maybe in by the end of this financial year or something like that.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- in the next year we are trying to reach total number of 100 plus dossier approvals or registrations which will (management committed by FY28)
- we are looking to double that number. (management committed by FY27)
Evidence
- Sakar Healthcare Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Consolidated and Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2025".(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%